Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M177,633Revenue (TTM) $M40,015Net Margin (%)12.7Altman Z-Score3.5
Enterprise Value $M190,802EPS (TTM) $1.8Operating Margin %18.3Piotroski F-Score8
P/E(ttm)35.4Beneish M-Score-2.7Pre-tax Margin (%)14.9Higher ROA y-yY
Price/Book4.510-y EBITDA Growth Rate %3.4Quick Ratio1.2Cash flow > EarningsY
Price/Sales4.55-y EBITDA Growth Rate %-3.4Current Ratio1.5Lower Leverage y-yY
Price/Free Cash Flow21.2y-y EBITDA Growth Rate %-12.9ROA % (ttm)5.3Higher Current Ratio y-yN
Dividend Yield %2.9PEG--ROE % (ttm)12.3Less Shares Outstanding y-yY
Payout Ratio %101Shares Outstanding M2,727ROIC % (ttm)10.9Gross Margin Increase y-yY

Gurus Latest Trades with MRK

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

MRK is held by these investors:

MRK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KIDDER C ROBERTDirector 2017-05-12Sell5,000$63.542.5view
Schechter Adam HEVP & Pres-Global Human Health 2017-04-03Sell53,850$63.482.6view
Karachun Rita ASr. VP Fince-Global Controller 2017-02-14Sell2,954$64.730.62view
RUSSO PATRICIA FDirector 2017-02-08Sell5,000$64.421.1view
WEEKS WENDELL PDirector 2017-02-06Sell5,000$64.510.96view
WENDELL PETER CDirector 2017-02-03Sell15,000$63.692.26view
Holston Michael JEVP, General Counsel 2017-02-03Sell91,959$63.961.83view
Schechter Adam HEVP & Pres-Global Human Health 2017-02-03Sell36,335$63.732.2view
Cech Thomas RDirector 2017-02-03Sell5,000$63.422.7view
FRAZIER KENNETH CChairman, President & CEO 2016-11-10Sell140,000$65.030.15view

Press Releases about MRK :

Quarterly/Annual Reports about MRK:

News about MRK:

Articles On GuruFocus.com
2 Important Dates for Big Pharma Sep 20 2017 
Dow Jones Closes at New High Sep 15 2017 
OncoSec Seeks Accelerated Approval to Treat Melanoma Sep 11 2017 
US Market Indexes End the Month Higher Sep 01 2017 
US Market Indexes Mostly Higher on Monday Aug 29 2017 
Large-Cap Stocks Gain on Monday Aug 22 2017 
Vanguard Sells Medtronic, Cigna in 2nd Quarter Aug 17 2017 
US Market Indexes Lower With Geopolitical Concerns Aug 09 2017 
Tech Stocks Lower on Thursday Jul 28 2017 
Mandy Moore and Merck Encourage Women to Plan Ahead in Her Life. Her Adventures. Campaign Jul 27 2017 

More From Other Websites
AstraZeneca Stock Upgraded: What You Need to Know Sep 22 2017
Pfizer-Merck KGaA Skin Cancer Drug Bavencio Gets EU Approval Sep 22 2017
See what the IHS Markit Score report has to say about Merck & Co Inc. Sep 22 2017
Better Buy: Celgene Corporation vs. Merck & Co., Inc. Sep 22 2017
Pfizer and Johnson & Johnson's Brewing Brawl Gets Real Sep 20 2017
2 Important Dates for Big Pharma Sep 20 2017
New First Line Treatment Now Available for Canadians with Metastatic Non-Small Cell Lung Cancer Sep 20 2017
Pro Baseball Hall of Famer and Cancer Survivor Mike Schmidt Joins Merck, Jim Kelly and Leading... Sep 19 2017
Buy Bristol-Myers Squibb Co (BMY) Stock With No Fear Sep 18 2017
The Top Cancer Immunotherapies Expected to Reach $1 Billion in Sales in 2017 Sep 18 2017
Dow Jones Closes at New High Sep 15 2017
Major Pharma Short Interest Surges Sep 13 2017
Bristol-Myers Reports Positive Results from Melanoma Study Sep 12 2017
Now Available in Canada: ISENTRESS® HD (raltegravir), a New Once-Daily Option, in Combination with... Sep 12 2017
Supercharge Your Portfolio With Amgen, Inc. (AMGN) Stock Sep 12 2017
Merck Announces Findings from Phase 3 Study of KEYTRUDA® (pembrolizumab), Compared to Standard of... Sep 11 2017
Merck’s KEYTRUDA® (pembrolizumab) Continues to Show Overall Survival Benefit Over Chemotherapy... Sep 10 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat